News
Chen, Y., et al. (2025). CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury. Acta Pharmaceutica Sinica B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback